Clinical Trial Offered to Patients with Rare and Hard to Treat Forms of Cancer
The Rutgers Cancer Institute of New Jersey and is joining forces with its System Partner Meridian Health in offering patients with rare forms of cancer or with cancer that no longer responds to standard treatment a chance to participate in a clinical trial.